Dr Freddie Bartlett
Consultant Clinical Oncologist
MB BS MRCP FRCR MD(Res)
I was appointed as a Consultant Clinical Oncologist at Portsmouth Hospitals NHS Trust in 2015. I am also a visiting Consultant at St Richard’s Hospital, Chichester.
I specialise in the treatment of breast and upper gastrointestinal cancers. I trained in London and the South of England and subsequently undertook a three year research degree into heart-sparing breast radiotherapy techniques at the Royal Marsden Hospital and the Institute of Cancer Research. I have published and spoken extensively on this subject and my work has changed UK breast radiotherapy practice. I also have a particular interest in diet and its role in cancer prevention and treatment.
I specialise in the treatment of breast, oesophagus, stomach, pancreas and gallbladder/bile duct cancers. In treating these cancers I have expertise in hormone therapy, chemotherapy and radiotherapy (including advanced radiotherapy techniques).
Some of the principal treatments carried out by Dr Freddie Bartlett at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Portsmouth Hospital.
BSc / Imperial College School of Medicine, London / 2001
Neurosciences and Basic Biomedical Sciences
Medicine and surgery / Imperial College School of Medicine, London / 2003
MRCP / Royal College of Physicians / 2006
Membership of the Royal Colleges of Physicians
MD(Res) / Institute of Cancer Research, London / 2015
Doctor of Medicine (Research)
FRCR / Royal College of Radiologists / 2010
Fellowship of the Royal College of Radiologists
Royal College of Radiologists h
I am Deputy Chair of the Wessex Radiotherapy Network Group
A randomised control trial evaluating fluorescent ink versus dark ink tattoos for breast radiotherapy.
Mean heart dose variation over a course of breath holding breast cancer radiotherapy.
A cardiac contouring atlas for radiotherapy.
The UK HeartSpare Study (Stage II): Multicentre evaluation of a voluntary breathhold technique in patients receiving breast radiotherapy.
The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breathhold technique and prone radiotherapy after breast conserving surgery.
Voluntary breathholding for breast cancer radiotherapy is consistent and stable.
Consultant Clinical Oncologist at Queen Alexandra Hospital, Portsmouth and St Richard's Hospital, Chichester
Although I have a passion for my work, I enjoy spending time with my young family, getting out in my dinghy in Chichester Harbour and going for walks up on the South Downs.
|Private secretary||Deborah Otter|
|Private secretary telephone||02393 277 022 / 07880 303 665|
|Private secretary email||Deborah.Otter@genesiscare.co.uk|